BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.391,82 PKT +24,39 PKT +1,78 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
07.05.14 Novartis buy UBS AG
07.05.14 Holcim overweight JP Morgan Chase & Co.
07.05.14 UBS overweight JP Morgan Chase & Co.
06.05.14 UBS buy UBS AG
05.05.14 ABB (Asea Brown Boveri) Sell Goldman Sachs Group Inc.
05.05.14 Givaudan Sell Goldman Sachs Group Inc.
02.05.14 Novartis buy Jefferies & Company Inc.
02.05.14 UBS buy Nomura
02.05.14 UBS overweight Morgan Stanley
30.04.14 ABB (Asea Brown Boveri) Halten Independent Research GmbH
30.04.14 ABB (Asea Brown Boveri) Hold Deutsche Bank AG
30.04.14 ABB (Asea Brown Boveri) Underperform BNP PARIBAS
30.04.14 ABB (Asea Brown Boveri) Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
30.04.14 ABB (Asea Brown Boveri) Equal weight Barclays Capital
30.04.14 ABB (Asea Brown Boveri) Neutral JP Morgan Chase & Co.
30.04.14 Novartis overweight JP Morgan Chase & Co.
30.04.14 Swiss Re overweight Morgan Stanley
30.04.14 ABB (Asea Brown Boveri) Neutral UBS AG
29.04.14 Swiss Re Underweight JP Morgan Chase & Co.
29.04.14 Swiss Re Neutral BNP PARIBAS
29.04.14 ABB (Asea Brown Boveri) Hold Société Générale Group S.A. (SG)
29.04.14 Novartis Underweight Morgan Stanley
29.04.14 Novartis buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.04.14 Roche overweight JP Morgan Chase & Co.
28.04.14 Roche overweight JP Morgan Chase & Co.
25.04.14 Holcim market-perform Bernstein Research
25.04.14 Holcim market-perform Bernstein Research
25.04.14 Novartis Hold Deutsche Bank AG
25.04.14 Holcim buy UBS AG
24.04.14 Novartis Halten Independent Research GmbH
24.04.14 UBS Hold Commerzbank AG
24.04.14 Novartis buy UBS AG
24.04.14 ABB (Asea Brown Boveri) Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
23.04.14 Novartis buy Société Générale Group S.A. (SG)
23.04.14 Novartis buy S&P Capital IQ
23.04.14 Novartis Underweight Barclays Capital
23.04.14 Novartis buy UBS AG
23.04.14 Novartis Hold Deutsche Bank AG
22.04.14 UBS buy S&P Capital IQ
22.04.14 Novartis Neutral JP Morgan Chase & Co.